OverviewChartNewsTraderScreen

L&S Knock-Out Teva Pharmaceutical.../  DE000LX3R395  /

EUWAX
17/05/2024  08:14:24 Chg.-0.040 Bid16:59:37 Ask16:59:37 Underlying Strike price Expiration date Option type
0.610EUR -6.15% 0.620
Bid Size: 5,000		 0.630
Ask Size: 5,000		 - 9.00 EUR 12/06/2024 Call
GlobeNewswire 14:04 INVESTIGATION ANNOUNCEMENT BFA LLP Announces an Ongoing Investigation into the Merger between WideOp...
GlobeNewswire 14:03 INVESTIGATION ANNOUNCEMENT BFA LLP Announces an Ongoing Investigation into the Directors of Ventyx B...
GlobeNewswire 13:12 INVESTIGATION ANNOUNCEMENT: BFA Law Announces an Ongoing Investigation into the Merger between Cerev...
GlobeNewswire 13:07 LAWSUIT ANNOUNCEMENT: BFA Law Encourages Sprout Social Investors to Contact the Firm About the Pendi...
GlobeNewswire 13:07 INVESTIGATION ANNOUNCEMENT: BFA Law Announces an Ongoing Investigation into the Buyout of Squarespac...
GlobeNewswire 14/05 VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) SHAREHOLDER ALERT: The Directors of Ventyx Biosciences, Inc....
GlobeNewswire 14/05 SPROUT SOCIAL, INC. LITIGATION ALERT (NASDAQ: SPT): Sprout Social Sued For Violations of the Federal...
GlobeNewswire 14/05 CEREVEL THERAPEUTICS HOLDINGS, INC. (NASDAQ: CERE) INVESTIGATION ALERT: Is $45 per CERE Share Enough...
GlobeNewswire 14/05 SQUARESPACE, INC. (NYSE: SQSP) SHAREHOLDER ALERT: Squarespace is Being Investigated In Connection Wi...
GlobeNewswire 14/05 Leading Law Firm Bleichmar Fonti & Auld LLP announces an investigation of WideOpenWest, Inc.’s (NYSE...
GlobeNewswire 13/05 Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (...
GlobeNewswire 11/05 VENTYX BIOSCIENCES, INC. INVESTOR ALERT (NASDAQ: VTYX): The Directors of Ventyx Biosciences, Inc. Ar...
GlobeNewswire 11/05 SPROUT SOCIAL, INC. STOCK DROP ALERT (NASDAQ: SPT): Sprout Social Stock Falls After Earnings; Top La...
GlobeNewswire 02/05 Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
GlobeNewswire 30/04 U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...
GlobeNewswire 24/04 Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimil...
GlobeNewswire 19/04 Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable...
GlobeNewswire 16/04 Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
GlobeNewswire 03/04 Alvotech Hosts Audio Call for Investors at 8:15 am EDT on April 3, 2024
GlobeNewswire 22/03 Alvotech Announces Increase in Number of Own Shares
GlobeNewswire 20/03 Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
GlobeNewswire 06/03 iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
GlobeNewswire 05/03 Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
GlobeNewswire 29/02 Alvotech Appoints Interim Chief Quality Officer
GlobeNewswire 26/02 Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purc...